Welcome to our dedicated page for Cardinal Health SEC filings (Ticker: CAH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cardinal Health, Inc. filings document material events for a healthcare distribution and medical products company, including quarterly results, Regulation FD outlook updates and earnings presentation exhibits. The records tie financial reporting to segment performance, capital returns, debt reduction and corporate finance matters such as revolving credit agreements that support the commercial paper program.
Governance filings cover board composition, annual meeting voting results, director and officer transitions, and related compensation or succession disclosures. The company’s 8-K record also includes material definitive agreements, shareholder voting matters, financial covenants, exhibits and other capital-structure disclosures for Cardinal Health’s public-company profile.
Cardinal Health Inc. (CAH) reported the initial share ownership of its Chief Human Resources Officer, Valerie Christine Pitteroff, in a Form 3 filing. She beneficially owns 4,040 Common Shares directly. In addition, she has an indirect interest in 463 Common Shares held through a 401(k) plan. This filing establishes her baseline ownership position as an officer of the company and does not reflect any new purchase or sale transactions.
Cardinal Health Inc. reported an insider equity transaction by its Chief Legal/Compliance Officer. On 12/01/2025, the officer had 422 common shares disposed of in a transaction coded "F," which represents shares withheld to cover tax obligations related to restricted share units. The price used for the withholding was the closing share price of $212.26 on the prior business day.
After this tax withholding event and an adjustment for shares transferred under a domestic relations order, the officer beneficially owned 34,427 common shares directly. The filing notes that these share withholdings are administrative in nature and tied to equity compensation rather than an open-market sale.
Cardinal Health reported a routine insider transaction by the CEO of its PSS segment. On 12/01/2025, 551 common shares of Cardinal Health were withheld at a price of $212.26 per share to cover the executive’s tax obligations related to restricted share units. After this tax withholding, the reporting person directly beneficially owns 52,877 common shares of Cardinal Health.
Cardinal Health Inc. reported an insider share transaction by its Chief Accounting Officer. On 12/01/2025, the officer had 61 common shares withheld and disposed of to cover tax obligations related to restricted share units, at a reference price of $212.26 per share. After this tax-related withholding, the officer beneficially owned 3,495 Cardinal Health common shares directly. The filing is administrative in nature and reflects routine equity compensation and associated tax withholding.
Cardinal Health Inc. executive reports routine share withholding for taxes. The CEO of the GMPD segment filed a Form 4 reporting that on 12/01/2025, 595 Cardinal Health common shares were withheld at a price of $212.26 per share to cover tax obligations related to restricted share units. After this transaction, the reporting person beneficially owned 25,490 common shares directly. The filing notes that this was a non-open-market transaction classified under code "F," meaning it reflects shares withheld by the company rather than a discretionary sale in the market.
Cardinal Health (CAH) disclosed a director equity grant on a Form 4. On 11/05/2025, a director acquired 1,067 restricted share units (Transaction Code A) at a stated price of $0. These RSUs will vest on November 5, 2026, or on the date of the 2026 Annual Meeting of Shareholders if that meeting occurs before November 5, 2026.
Following this award, the director beneficially owned 2,116 common shares, held directly. This filing reflects routine director compensation in equity and does not indicate an open-market purchase or sale.
Cardinal Health (CAH) reported an insider equity grant on a Form 4. A director acquired 1,067 common shares on 11/05/2025 via a restricted share unit award at $0. Following this grant, the director beneficially owns 2,116 shares, held directly.
The restricted share units will vest on November 5, 2026, or on the date of the 2026 Annual Meeting of Shareholders if that meeting occurs earlier.
Cardinal Health (CAH) director reported an equity award. On 11/05/2025, the reporting person acquired 1,067 restricted share units at no cost. The award will vest on November 5, 2026, or on the date of the 2026 Annual Meeting of Shareholders if that meeting occurs earlier. Following this grant, the director beneficially owned 7,536 common shares directly.
Cardinal Health (CAH) director reported a routine equity grant on 11/05/2025. The filing shows an acquisition of 1,067 common shares at $0, reflecting a grant of restricted share units. Following the transaction, the director’s beneficial ownership stands at 27,624 shares, held directly.
The restricted share units will vest on November 5, 2026, or if the 2026 Annual Meeting of Shareholders occurs earlier, on the meeting date.
Cardinal Health (CAH) reported an insider equity award. A company director acquired 1,702 common shares on 11/05/2025 via an award priced at $0, reflecting a grant of restricted share units. Following the transaction, the director beneficially owns 64,194 shares directly.
The restricted share units are scheduled to vest on November 5, 2026, or on the date of the 2026 Annual Meeting of Shareholders if that meeting occurs before November 5, 2026.